Polynucleotides (Eyes)
Polynucleotides for Eyes: Rejuvenate Your Look with Advanced Skin Boosters
Overview
Are you looking to brighten and rejuvenate the delicate skin around your eyes? Polynucleotides eye treatment at Apothecary Dermatique in Wimborne, Dorset offers a cutting-edge solution to reduce fine lines, wrinkles, and dark circles. Administered by Jooman Abass, a Pharmacist Independent Prescriber, this treatment aims to boost collagen and elastin for a refreshed and youthful appearance.
About Treatment
Benefits of the treatment
How the treatment work?
Polynucleotides work by utilizing the regenerative properties of nucleotides to repair and revitalize skin tissue. These skin boosters, similar to Profhilo, Seventy Hyal, and other advanced treatments, are injected into the under-eye area, stimulating collagen production and improving skin elasticity.
Who is this treatment for?
The ideal candidate for polynucleotides eye treatment includes individuals struggling with under-eye bags, fine lines, dark circles, and crepey skin. If you're seeking a non-surgical solution to enhance the appearance of your eyes, you may benefit from this treatment.
What to expect during treatment?
During the procedure, Jooman Abass will carefully inject polynucleotides into the targeted under-eye area using fine needles. The process is minimally invasive, taking approximately 30 minutes, and is typically well-tolerated with minimal discomfort.
Before and after-care
Patients can expect noticeable improvements in skin texture, elasticity, and hydration. Similar to Profhilo before and after treatments, results typically become visible a few weeks post-procedure, with optimal outcomes achieved after multiple sessions.
Recovery
Recovery time is minimal, with most patients experiencing only mild swelling or redness that subsides within a few days. Aftercare instructions may include avoiding strenuous activities and direct sun exposure for a short period. Consistent hydration and use of gentle skincare products will further enhance your results.